NCT03962140

Brief Summary

This study is a retrospective study to investigate the association between body fat distribution and sarcopenia on CT-scan and oncological outcomes in endometrial cancer patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
302

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 23, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

September 16, 2021

Status Verified

September 1, 2021

Enrollment Period

1.6 years

First QC Date

April 17, 2019

Last Update Submit

September 15, 2021

Conditions

Keywords

Endometrial CancerCT-scanFat distributionObesitySarcopenia

Outcome Measures

Primary Outcomes (1)

  • The Investigation of Patients with High BMI and Survival Rates

    To investigate the association between body fat distribution and sarcopenia on CT-scan and survival in endometrial cancer patients

    10 years

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Endometrial cancer patients

You may qualify if:

  • Confirmed diagnosis of endometrial cancer
  • Age: 18 years or older
  • Abdominal CT-scan as part of pre-operative or post-operative staging work-up (\<1 month after surgery)

You may not qualify if:

  • Women with concurrent cancer
  • Women with unknown body mass index

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Cornwall Hospital

Truro, Cornwall, TR1 3LJ, United Kingdom

Location

MeSH Terms

Conditions

Endometrial NeoplasmsObesitySarcopenia

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, Anatomical

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2019

First Posted

May 23, 2019

Study Start

August 1, 2019

Primary Completion

March 1, 2021

Study Completion

March 31, 2021

Last Updated

September 16, 2021

Record last verified: 2021-09

Locations